1 Market Overview
1.1 STD Diagnostics Product Introduction
1.2 Global STD Diagnostics Market Size Forecast
1.3 STD Diagnostics Market Trends & Drivers
1.3.1 STD Diagnostics Industry Trends
1.3.2 STD Diagnostics Market Drivers & Opportunity
1.3.3 STD Diagnostics Market Challenges
1.3.4 STD Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global STD Diagnostics Players Revenue Ranking (2024)
2.2 Global STD Diagnostics Revenue by Company (2019-2025)
2.3 Key Companies STD Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies STD Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of STD Diagnostics
2.6 STD Diagnostics Market Competitive Analysis
2.6.1 STD Diagnostics Market Concentration Rate (2019-2025)
2.6.2 Global 5 and 10 Largest Companies by STD Diagnostics Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chlamydia Testing
3.1.2 Syphilis Testing
3.1.3 Gonorrhea Testing
3.1.4 Herpes Simplex Virus Testing
3.1.5 Human Papilloma Virus Testing
3.1.6 Human Immunodeficiency Virus Testing
3.1.7 Chancroid Testing
3.2 Global STD Diagnostics Sales Value by Type
3.2.1 Global STD Diagnostics Sales Value by Type (2019 VS 2024 VS 2034)
3.2.2 Global STD Diagnostics Sales Value, by Type (2019-2034)
3.2.3 Global STD Diagnostics Sales Value, by Type (%) (2019-2034)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory Testing
4.1.2 Point of Care Testing
4.2 Global STD Diagnostics Sales Value by Application
4.2.1 Global STD Diagnostics Sales Value by Application (2019 VS 2024 VS 2034)
4.2.2 Global STD Diagnostics Sales Value, by Application (2019-2034)
4.2.3 Global STD Diagnostics Sales Value, by Application (%) (2019-2034)
5 Segmentation by Region
5.1 Global STD Diagnostics Sales Value by Region
5.1.1 Global STD Diagnostics Sales Value by Region: 2019 VS 2024 VS 2034
5.1.2 Global STD Diagnostics Sales Value by Region (2019-2025)
5.1.3 Global STD Diagnostics Sales Value by Region (2025-2034)
5.1.4 Global STD Diagnostics Sales Value by Region (%), (2019-2034)
5.2 North America
5.2.1 North America STD Diagnostics Sales Value, 2019-2034
5.2.2 North America STD Diagnostics Sales Value by Country (%), 2024 VS 2034
5.3 Europe
5.3.1 Europe STD Diagnostics Sales Value, 2019-2034
5.3.2 Europe STD Diagnostics Sales Value by Country (%), 2024 VS 2034
5.4 Asia Pacific
5.4.1 Asia Pacific STD Diagnostics Sales Value, 2019-2034
5.4.2 Asia Pacific STD Diagnostics Sales Value by Country (%), 2024 VS 2034
5.5 South America
5.5.1 South America STD Diagnostics Sales Value, 2019-2034
5.5.2 South America STD Diagnostics Sales Value by Country (%), 2024 VS 2034
5.6 Middle East & Africa
5.6.1 Middle East & Africa STD Diagnostics Sales Value, 2019-2034
5.6.2 Middle East & Africa STD Diagnostics Sales Value by Country (%), 2024 VS 2034
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions STD Diagnostics Sales Value Growth Trends, 2019 VS 2024 VS 2034
6.2 Key Countries/Regions STD Diagnostics Sales Value
6.3 United States
6.3.1 United States STD Diagnostics Sales Value, 2019-2034
6.3.2 United States STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.3.3 United States STD Diagnostics Sales Value by Application, 2024 VS 2034
6.4 Europe
6.4.1 Europe STD Diagnostics Sales Value, 2019-2034
6.4.2 Europe STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.4.3 Europe STD Diagnostics Sales Value by Application, 2024 VS 2034
6.5 China
6.5.1 China STD Diagnostics Sales Value, 2019-2034
6.5.2 China STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.5.3 China STD Diagnostics Sales Value by Application, 2024 VS 2034
6.6 Japan
6.6.1 Japan STD Diagnostics Sales Value, 2019-2034
6.6.2 Japan STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.6.3 Japan STD Diagnostics Sales Value by Application, 2024 VS 2034
6.7 South Korea
6.7.1 South Korea STD Diagnostics Sales Value, 2019-2034
6.7.2 South Korea STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.7.3 South Korea STD Diagnostics Sales Value by Application, 2024 VS 2034
6.8 Southeast Asia
6.8.1 Southeast Asia STD Diagnostics Sales Value, 2019-2034
6.8.2 Southeast Asia STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.8.3 Southeast Asia STD Diagnostics Sales Value by Application, 2024 VS 2034
6.9 India
6.9.1 India STD Diagnostics Sales Value, 2019-2034
6.9.2 India STD Diagnostics Sales Value by Type (%), 2024 VS 2034
6.9.3 India STD Diagnostics Sales Value by Application, 2024 VS 2034
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott STD Diagnostics Products, Services and Solutions
7.1.4 Abbott STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.1.5 Abbott Recent Developments
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Profile
7.2.2 ADI/American Diagnostica Main Business
7.2.3 ADI/American Diagnostica STD Diagnostics Products, Services and Solutions
7.2.4 ADI/American Diagnostica STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.2.5 ADI/American Diagnostica Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies STD Diagnostics Products, Services and Solutions
7.3.4 Agilent Technologies STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.3.5 Alere/Biosite/Inverness Recent Developments
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Profile
7.4.2 Alere/Biosite/Inverness Main Business
7.4.3 Alere/Biosite/Inverness STD Diagnostics Products, Services and Solutions
7.4.4 Alere/Biosite/Inverness STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.4.5 Alere/Biosite/Inverness Recent Developments
7.5 Axis-Shield
7.5.1 Axis-Shield Profile
7.5.2 Axis-Shield Main Business
7.5.3 Axis-Shield STD Diagnostics Products, Services and Solutions
7.5.4 Axis-Shield STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.5.5 Axis-Shield Recent Developments
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Profile
7.6.2 Beckman Coulter/Danaher Main Business
7.6.3 Beckman Coulter/Danaher STD Diagnostics Products, Services and Solutions
7.6.4 Beckman Coulter/Danaher STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.6.5 Beckman Coulter/Danaher Recent Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Profile
7.7.2 Becton Dickinson Main Business
7.7.3 Becton Dickinson STD Diagnostics Products, Services and Solutions
7.7.4 Becton Dickinson STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.7.5 Becton Dickinson Recent Developments
7.8 Bio/Data
7.8.1 Bio/Data Profile
7.8.2 Bio/Data Main Business
7.8.3 Bio/Data STD Diagnostics Products, Services and Solutions
7.8.4 Bio/Data STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.8.5 Bio/Data Recent Developments
7.9 Decode Genetics
7.9.1 Decode Genetics Profile
7.9.2 Decode Genetics Main Business
7.9.3 Decode Genetics STD Diagnostics Products, Services and Solutions
7.9.4 Decode Genetics STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.9.5 Decode Genetics Recent Developments
7.10 Diadexus
7.10.1 Diadexus Profile
7.10.2 Diadexus Main Business
7.10.3 Diadexus STD Diagnostics Products, Services and Solutions
7.10.4 Diadexus STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.10.5 Diadexus Recent Developments
7.11 Diagnocure
7.11.1 Diagnocure Profile
7.11.2 Diagnocure Main Business
7.11.3 Diagnocure STD Diagnostics Products, Services and Solutions
7.11.4 Diagnocure STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.11.5 Diagnocure Recent Developments
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Profile
7.12.2 Diagnostica Stago/Trinity Biotech Main Business
7.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Products, Services and Solutions
7.12.4 Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.12.5 Diagnostica Stago/Trinity Biotech Recent Developments
7.13 Diamedix
7.13.1 Diamedix Profile
7.13.2 Diamedix Main Business
7.13.3 Diamedix STD Diagnostics Products, Services and Solutions
7.13.4 Diamedix STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.13.5 Diamedix Recent Developments
7.14 Polymedco
7.14.1 Polymedco Profile
7.14.2 Polymedco Main Business
7.14.3 Polymedco STD Diagnostics Products, Services and Solutions
7.14.4 Polymedco STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.14.5 Polymedco Recent Developments
7.15 Qiagen
7.15.1 Qiagen Profile
7.15.2 Qiagen Main Business
7.15.3 Qiagen STD Diagnostics Products, Services and Solutions
7.15.4 Qiagen STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.15.5 Qiagen Recent Developments
7.16 Roche
7.16.1 Roche Profile
7.16.2 Roche Main Business
7.16.3 Roche STD Diagnostics Products, Services and Solutions
7.16.4 Roche STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.16.5 Roche Recent Developments
7.17 SDIX
7.17.1 SDIX Profile
7.17.2 SDIX Main Business
7.17.3 SDIX STD Diagnostics Products, Services and Solutions
7.17.4 SDIX STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.17.5 SDIX Recent Developments
7.18 Sequenom
7.18.1 Sequenom Profile
7.18.2 Sequenom Main Business
7.18.3 Sequenom STD Diagnostics Products, Services and Solutions
7.18.4 Sequenom STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.18.5 Sequenom Recent Developments
7.19 Siemens
7.19.1 Siemens Profile
7.19.2 Siemens Main Business
7.19.3 Siemens STD Diagnostics Products, Services and Solutions
7.19.4 Siemens STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.19.5 Siemens Recent Developments
7.20 Sienco
7.20.1 Sienco Profile
7.20.2 Sienco Main Business
7.20.3 Sienco STD Diagnostics Products, Services and Solutions
7.20.4 Sienco STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.20.5 Sienco Recent Developments
7.21 Sysmex
7.21.1 Sysmex Profile
7.21.2 Sysmex Main Business
7.21.3 Sysmex STD Diagnostics Products, Services and Solutions
7.21.4 Sysmex STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.21.5 Sysmex Recent Developments
7.22 Takara Bio
7.22.1 Takara Bio Profile
7.22.2 Takara Bio Main Business
7.22.3 Takara Bio STD Diagnostics Products, Services and Solutions
7.22.4 Takara Bio STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.22.5 Takara Bio Recent Developments
7.23 ThermoFisher
7.23.1 ThermoFisher Profile
7.23.2 ThermoFisher Main Business
7.23.3 ThermoFisher STD Diagnostics Products, Services and Solutions
7.23.4 ThermoFisher STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.23.5 ThermoFisher Recent Developments
7.24 Tosoh
7.24.1 Tosoh Profile
7.24.2 Tosoh Main Business
7.24.3 Tosoh STD Diagnostics Products, Services and Solutions
7.24.4 Tosoh STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.24.5 Tosoh Recent Developments
7.25 Wako
7.25.1 Wako Profile
7.25.2 Wako Main Business
7.25.3 Wako STD Diagnostics Products, Services and Solutions
7.25.4 Wako STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.25.5 Wako Recent Developments
7.26 Zycare/Alere
7.26.1 Zycare/Alere Profile
7.26.2 Zycare/Alere Main Business
7.26.3 Zycare/Alere STD Diagnostics Products, Services and Solutions
7.26.4 Zycare/Alere STD Diagnostics Revenue (US$ Million) & (2019-2025)
7.26.5 Zycare/Alere Recent Developments
8 Industry Chain Analysis
8.1 STD Diagnostics Industrial Chain
8.2 STD Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 STD Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 STD Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
